tradingkey.logo

Verastem Oncology rises after $75 million private placement

ReutersApr 25, 2025 2:00 PM

Verastem Oncology's VSTM.O shares rise 4.8% to $7.86 in early trading

Cancer drug developer announces $75 million private placement led by investment firm RTW

Firm has agreed with investors for placement of $24 million of shares and $51 million of pre-funded warrants

Guggenheim Securities was the lead agent for the private placement

Proceeds will be used to fund the potential launch of its experimental cancer therapy avutometinib and other purposes

As of last close, VSTM stock up 45% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI